Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
University of California-Irvine's Institute for Clinical and Translations Science
AddedFeb 15, 2024
UpdatedJun 18, 2026
University of California-Irvine's Institute for Clinical and Translations Science

University of California-Irvine's Institute for Clinical and Translations Science

UC Irvine's ICTS, funded by NIH, is a leading institute in clinical and translational medical research.

HQ
Irvine, CA, US
Founded
1957
Overview
Compare
Fundraising
Employees
Website

The University of California-Irvine's Institute for Clinical and Translational Science (ICTS) was established with funding from the National Institutes of Health (NIH) under the Clinical and Translational Sciences Award (CTSA) program. The core mission of ICTS is to accelerate the translation of scientific discoveries into clinical applications to improve public health. The institute offers a range of services including biostatistics, epidemiology, clinical research ethics consultations, community engagement, and specialized support for diverse populations. ICTS focuses on fostering collaborative research efforts and providing educational opportunities to enhance the skills of clinical researchers.

Notable affiliates include leading researchers and faculty from UC Irvine, who contribute to its multidisciplinary approach. The institute has received significant NIH funding, underscoring its importance in the national landscape of medical research. Key achievements include numerous funded grants and successful pilot programs that have advanced clinical practices and community health initiatives. Overall, ICTS has made a substantial impact by bridging the gap between laboratory research and patient care, promoting innovation, and improving health outcomes through its comprehensive support and collaborative efforts.

Similar Companies

Michigan Institute for Clinical & Health Research logo

Michigan Institute for Clinical & Health Research

michr.umich.edu

National Institute of Health Research logo

National Institute of Health Research

University of Illinois at Chicago logo

University of Illinois at Chicago

uic.edu

Chipts logo

Chipts

chipts.ucla.edu

Scripps Research Institute logo

Scripps Research Institute

scripps.edu

Scripps Translational Science Institute logo

Scripps Translational Science Institute

stsiweb.org

UC San Diego logo

UC San Diego

ucsd.edu

University of Cincinnati logo

University of Cincinnati

uc.edu

UNC Institute for Trauma Recovery logo

UNC Institute for Trauma Recovery

med.unc.edu

Ucsd Student-Run Free Clinic Project logo

Ucsd Student-Run Free Clinic Project

Georgia Ctsa logo

Georgia Ctsa

georgiactsa.org

Translational Research Management logo

Translational Research Management

University of Colorado Anschutz Medical Campus logo

University of Colorado Anschutz Medical Campus

cuanschutz.edu

The Stark Neurosciences Research Institute logo

The Stark Neurosciences Research Institute

medicine.iu.edu

Quick Facts

Who are University of California-Irvine's Institute for Clinical and Translations Science's competitors?

Companies similar to University of California-Irvine's Institute for Clinical and Translations Science include Michigan Institute for Clinical & Health Research, National Institute of Health Research, University of Illinois at Chicago and Chipts.

When was University of California-Irvine's Institute for Clinical and Translations Science founded?

University of California-Irvine's Institute for Clinical and Translations Science was founded in 1957.

Where is University of California-Irvine's Institute for Clinical and Translations Science's headquarters located?

University of California-Irvine's Institute for Clinical and Translations Science's headquarters is located in Irvine, CA, US.

When was University of California-Irvine's Institute for Clinical and Translations Science's last funding round?

University of California-Irvine's Institute for Clinical and Translations Science's most recent funding round was for $24M (USD) in September 2019.

How much has University of California-Irvine's Institute for Clinical and Translations Science raised to-date?

As of Sep 20, 2019, University of California-Irvine's Institute for Clinical and Translations Science has raised a total of $24M (USD).

How many employees does University of California-Irvine's Institute for Clinical and Translations Science have?

University of California-Irvine's Institute for Clinical and Translations Science has 5 employees as of Feb 4, 2024.

Classification

Technology
  • HealthTech
Geographic Exposure
  • United States
Customer
  • Government
  • Non-Profit
Main Product
  • Medical Research
Tags
  • Consulting
NAICS
  • 610000Educational Services
  • 611000Educational Services
SIC
  • 8200Educational Services
  • 8290Schools And Educational Services, Not Elsewhere Classified